Close

Autolus Therapeutics (AUTL) announces pivotal Phase 2 FELIX clinical trial has met primary endpoint at interim analysis

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/23/2024

1. TSLA
2. GM
3. SPY
4. SHW
5. AMZN
6. SPOT
7. AAPL
8. NVDA
9. MTTR
10. IBM


Go back to Autolus Therapeutics (AUTL) announces pivotal Phase 2 FELIX clinical trial has met primary endpoint at interim analysis
(NASDAQ: AUTL) Delayed: 4.56 --0 (-0%)
Previous Close $4.56    52 Week High $ 
Open $4.58    52 Week Low $ 
Day High $4.71    P/E N/A 
Day Low $4.53    EPS $ 
Volume 1,330,355